Search

everythinglearnresearchcommunity

for

Search:↓

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Transplant patients often get skin problems, with treatments varying by condition.

Altered metabolism can help control seizures by changing brain signaling and energy use, suggesting new treatments for epilepsy.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Vitamin D receptor binds similarly to natural and synthetic ligands, affecting gene regulation.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

The testes produce important hormones like testosterone and others that play key roles in male body functions.

Environmental factors and chemicals might affect hormone balance and contribute to common hair loss.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Scopolin and scopoletin from Merremia peltata leaves may help treat hair loss and showed promising results in rabbit tests.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Menopause causes dry skin, wrinkles, and hair changes, with hormone therapy helping but not recommended just for these issues.

DHEA affects various tissues by interacting with multiple receptors and can be converted into sex hormones.

Growth hormone levels affect hair growth and loss, with too much causing excess hair and too little leading to hair loss.

Using certain hair products may increase breast cancer risk in black women.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Testosterone is crucial for development, growth, and various body functions in mammals.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.